Studies of In Vitro Activities of Voriconazole and Itraconazole against Aspergillus Hyphae Using Viability Staining
Open Access
- 1 January 2001
- journal article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 45 (1), 124-128
- https://doi.org/10.1128/aac.45.1.124-128.2001
Abstract
The minimal fungicidal concentrations (MFCs) of voriconazole and itraconazole for five clinical isolates each of Aspergillus terreus, Aspergillus fumigatus, Aspergillus flavus, and Aspergillus niger were determined by a broth macrodilution method. Conidial suspensions as inocula were compared to hyphae as inocula since the invasive form of aspergillosis is manifested by the appearance of hyphal structures. In addition, cell viability staining with the dye FUN-1 was performed to assess time-dependent damage of hyphae exposed to various concentrations of the antifungal agents. With conidial inocula the MFC ranges of voriconazole were 0.5 to 4 μg/ml and those of itraconazole were 0.25 to 2 μg/ml, whereas the MFCs (2 to >16 μg/ml) with hyphal inocula were substantially higher (P < 0.01) for both itraconazole and voriconazole. Only minor differences between the tested antifungals were observed since 16 of 20 and 17 of 20 of the isolates of Aspergillus spp. tested appeared to be killed by voriconazole and itraconazole, respectively. The results of FUN-1 viability staining correlated closely to colony counts, but various time- and dose-dependent levels of viability of hyphae were also observed. In conclusion, our study demonstrates the importance of the type of inoculum used to test antifungals and the applicability of FUN-1 staining as a rapid and sensitive method for assaying the viability of hyphae.Keywords
This publication has 29 references indexed in Scilit:
- In-vitro activity of voriconazole against Aspergillus spp. and comparison with itraconazole and amphotericin BJournal of Antimicrobial Chemotherapy, 1998
- Invasive AspergillosisClinical Infectious Diseases, 1998
- Fluorescent probes for wall porosity and membrane integrity in filamentous fungiJournal of Microbiological Methods, 1997
- Comparative and collaborative evaluation of standardization of antifungal susceptibility testing for filamentous fungiAntimicrobial Agents and Chemotherapy, 1995
- MMM1 encodes a mitochondrial outer membrane protein essential for establishing and maintaining the structure of yeast mitochondria.The Journal of cell biology, 1994
- Strategies in prevention of invasive pulmonary aspergillosis in immunosuppressed or neutropenic patientsAntimicrobial Agents and Chemotherapy, 1994
- Pulmonary Aspergillosis in the Acquired Immunodeficiency SyndromeNew England Journal of Medicine, 1991
- Epidemiology and pathogenesis of systemic fungal infections in the immunocompromised hostJournal of Antimicrobial Chemotherapy, 1991
- Antifungal and Surgical Treatment of Invasive Aspergillosis: Review of 2,121 Published CasesClinical Infectious Diseases, 1990
- Nosocomial Fungal Infections: A Classification for Hospital-Acquired Fungal Infections and Mycoses Arising from Endogenous Flora or ReactivationAnnual Review of Microbiology, 1988